Moxonidine Teva Sante (Moxonidine)

Moxonidine belongs to the imidazoline receptor agonist class and is employed in the management of high blood pressure.

• Essential hypertension: lowers systolic and diastolic blood pressure in adults with primary hypertension.
• Resistant hypertension: provides additional pressure reduction when used with other antihypertensive agents.
• Isolated systolic hypertension: helps control elevated systolic pressure, particularly in older patients.

• Moxonidine selectively stimulates I1 imidazoline receptors in the central nervous system, which reduces sympathetic outflow. This attenuation of sympathetic activity decreases peripheral vascular resistance and cardiac output, resulting in a modest but consistent reduction of arterial blood pressure.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dry mouth: sensation of oral dryness without obvious cause.
• Fatigue: feeling of tiredness or lack of energy.
• Dizziness: light‑headedness, especially when standing quickly.
• Headache: mild to moderate cranial pain.
• Nausea: upset stomach with urge to vomit.
• Constipation: infrequent, hard stools.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure that may cause fainting.
• Bradycardia: unusually slow heart rate requiring medical attention.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Liver dysfunction: abnormal liver enzymes or jaundice.
• Cardiac arrhythmia: irregular heart rhythm that can be life‑threatening.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients for safety concerns.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Renal impairment: adjust dose or use with caution in patients with reduced kidney function.
• Hepatic dysfunction: consider liver status, as metabolism may be affected.
• Elderly patients: start at lower dose and titrate slowly due to increased sensitivity.
• Discontinuation: avoid abrupt withdrawal; taper under medical supervision.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Moxonidine can interact with several drug classes, influencing blood pressure control or safety.

Major Interactions (Avoid)

• Combined with other antihypertensives (e.g., ACE inhibitors, ARBs, diuretics): may cause additive hypotensive effects.
• Clonidine or other central sympatholytics: risk of profound blood pressure drop.
• MAO inhibitors: potential for severe hypertension rebound on abrupt discontinuation.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive response.

• Beta‑blockers: additive heart‑rate slowing.
• Alcohol: can enhance dizziness and hypotension.
• Diuretics: may increase risk of electrolyte imbalance and low blood pressure.